Nanostim Leadless Cardiac Pacemaker

Nanostim Leadless Cardiac Pacemaker Recall Abbott is recalling Nanostim leadless cardiac pacemakers in Canada because the devices may unexpectedly stop delivering pacing therapy due to a potential electrical issue. The recall affects patients who have received this pacemaker implant. This is a Class I recall, meaning there is a reasonable probability that use of the product will cause serious adverse health consequences or death.

Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DEVICES
Recall date
2016-11-07
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/8f8f07c7-2033-400e-8199-137e63499321